MedPath

Etude Tomos- Apport de la Tomosynthèse Dans le Bilan d'Extension locorégional préthérapeutique d'Une Tumeur du Sein : Recherche de multicentricité Tomos Study- Contribution of Tomosynthesis In Locoregional Pretherapeutic Staging of a Breast Tumor: Multicentricity Search

Phase 2
Terminated
Conditions
Mammary Tumor
Registration Number
NCT01522300
Lead Sponsor
Centre Jean Perrin
Brief Summary

The main objective of the study is to assess the sensitivity and specificity of Tomosynthesis in detecting the multicentricity of mammary tumor.

Detailed Description

The secondaries objectives of the study are:

* Sensitivity and specificity in detecting multifocality of breast tumor

* Sensitivity and specificity of Tomosynthesis in the detection of contralateral tumors

* Predetermination of potential targets for ultrasound

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
81
Inclusion Criteria
  • Age> 18 years.
  • Patients with a breast tumor, regardless of the stage and size
  • Compulsory affiliation to a social security system.
  • Obtaining informed consent in writing, signed and dated.
Exclusion Criteria
  • Patients with cognitive or psychiatric disorders.
  • Patient deprived of liberty by a court or administrative.
  • Patients with indications against the achievement of MRI, mammography and tomosynthesis
  • Pregnant Women

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
To calculate the sensitivity and specificity of both types of imaging (mammography and Tomosynthesis) with respect to number of tumors multicentric and multifocal identified through MRI.January 2013

To calculate the sensitivity and specificity of both types of imaging (mammography and Tomosynthesis) with respect to number of tumors multicentric and multifocal identified through MRI. The other parameters VPN, VPP will also be calculated and discussed.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Centre Jean Perrin

🇫🇷

Clermont Ferrand, France

Centre Jean Perrin
🇫🇷Clermont Ferrand, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.